SK2632003A3 - The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione - Google Patents

The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Download PDF

Info

Publication number
SK2632003A3
SK2632003A3 SK263-2003A SK2632003A SK2632003A3 SK 2632003 A3 SK2632003 A3 SK 2632003A3 SK 2632003 A SK2632003 A SK 2632003A SK 2632003 A3 SK2632003 A3 SK 2632003A3
Authority
SK
Slovakia
Prior art keywords
substantially identical
hydrochloride
hydrochloride salt
compound
pyridyl
Prior art date
Application number
SK263-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK2632003A3 publication Critical patent/SK2632003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK263-2003A 2000-09-06 2001-09-05 The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione SK2632003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021865.1A GB0021865D0 (en) 2000-09-06 2000-09-06 Novel pharmaceutical
PCT/GB2001/003991 WO2002020519A1 (fr) 2000-09-06 2001-09-05 Sels hydrochloridrates de 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
SK2632003A3 true SK2632003A3 (en) 2003-12-02

Family

ID=9898953

Family Applications (1)

Application Number Title Priority Date Filing Date
SK263-2003A SK2632003A3 (en) 2000-09-06 2001-09-05 The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Country Status (35)

Country Link
US (3) US20040034066A1 (fr)
EP (1) EP1315723B1 (fr)
JP (1) JP2004508369A (fr)
KR (1) KR100770513B1 (fr)
CN (1) CN100558717C (fr)
AP (1) AP1715A (fr)
AT (1) ATE300538T1 (fr)
AU (2) AU8428401A (fr)
BG (1) BG107607A (fr)
BR (1) BR0113713A (fr)
CA (1) CA2421213A1 (fr)
CY (1) CY1105252T1 (fr)
CZ (1) CZ302125B6 (fr)
DE (1) DE60112310T2 (fr)
DK (1) DK1315723T3 (fr)
DZ (1) DZ3475A1 (fr)
EA (1) EA004296B1 (fr)
EC (1) ECSP034505A (fr)
ES (1) ES2244647T3 (fr)
GB (1) GB0021865D0 (fr)
HK (1) HK1057749A1 (fr)
HU (1) HUP0300938A3 (fr)
IL (2) IL154724A0 (fr)
MA (1) MA25908A1 (fr)
MX (1) MXPA03001956A (fr)
NO (1) NO324020B1 (fr)
NZ (1) NZ524548A (fr)
OA (1) OA12375A (fr)
PL (1) PL360578A1 (fr)
PT (1) PT1315723E (fr)
SI (1) SI1315723T1 (fr)
SK (1) SK2632003A3 (fr)
UA (1) UA74003C2 (fr)
WO (1) WO2002020519A1 (fr)
ZA (1) ZA200301809B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
JP5063714B2 (ja) * 2010-01-29 2012-10-31 シャープ株式会社 画像読取装置及び画像形成装置
EP2508525A1 (fr) 2011-04-05 2012-10-10 Bayer Pharma Aktiengesellschaft Sels de 2,3-dihydroimidazo[1,2-C]quinazoline substitutés
RU2487132C1 (ru) * 2012-07-23 2013-07-10 Общество с ограниченной ответственностью "Метаген" Производные циклических 5-нитропиридин-2-ил-тиоалкенил-4-дитиокарбаматов, обладающие противогрибковой активностью, и их применение

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
EP0896182B1 (fr) * 1997-07-17 2002-04-10 Interlemo Holding S.A. Système connecteur
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
NO20031020L (no) 2003-05-06
ES2244647T3 (es) 2005-12-16
US20070191435A1 (en) 2007-08-16
OA12375A (en) 2004-03-19
MXPA03001956A (es) 2003-06-24
CY1105252T1 (el) 2010-03-03
HUP0300938A2 (hu) 2003-11-28
PL360578A1 (en) 2004-09-06
HUP0300938A3 (en) 2005-04-28
BG107607A (bg) 2003-12-31
DE60112310D1 (de) 2005-09-01
CA2421213A1 (fr) 2002-03-14
UA74003C2 (en) 2005-10-17
NO20031020D0 (no) 2003-03-05
IL154724A0 (en) 2003-10-31
US20050282867A1 (en) 2005-12-22
KR20030027118A (ko) 2003-04-03
ECSP034505A (es) 2003-06-25
CN100558717C (zh) 2009-11-11
AU8428401A (en) 2002-03-22
CZ302125B6 (cs) 2010-11-03
KR100770513B1 (ko) 2007-10-25
EP1315723A1 (fr) 2003-06-04
DE60112310T2 (de) 2006-02-09
NO324020B1 (no) 2007-07-30
DK1315723T3 (da) 2005-10-24
IL154724A (en) 2009-07-20
HK1057749A1 (en) 2004-04-16
AU2001284284B2 (en) 2005-08-04
PT1315723E (pt) 2005-11-30
EP1315723B1 (fr) 2005-07-27
SI1315723T1 (en) 2005-10-31
BR0113713A (pt) 2004-07-06
EA200300345A1 (ru) 2003-08-28
NZ524548A (en) 2004-10-29
CZ2003615A3 (cs) 2003-11-12
US20040034066A1 (en) 2004-02-19
GB0021865D0 (en) 2000-10-18
AP1715A (en) 2007-02-28
ATE300538T1 (de) 2005-08-15
JP2004508369A (ja) 2004-03-18
DZ3475A1 (fr) 2002-03-14
WO2002020519A1 (fr) 2002-03-14
MA25908A1 (fr) 2003-10-01
AP2003002758A0 (en) 2003-06-30
CN1366520A (zh) 2002-08-28
EA004296B1 (ru) 2004-02-26
ZA200301809B (en) 2004-04-19

Similar Documents

Publication Publication Date Title
SK13302002A3 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino) etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
US20070191435A1 (en) Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1442003A3 (en) Tartrate salts of thiazolidinedione derivative
EP1305311B1 (fr) Tartrate de derive de thiazolidinedione
KR20040062965A (ko) 로시글리타존 에디실레이트 및 항당뇨제로서의 그의 용도
KR100917953B1 (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온의 나트륨염
SK1452003A3 (en) Tartrate salts of thiazolidinedione derivative
SK287243B6 (sk) Soľ 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoxy]benzyl]thiazolidín- 2,4-diónu a kyseliny L (+) vínnej, spôsob jej prípravy a použitie, farmaceutická kompozícia s jej obsahom
SK3792003A3 (en) A thiazolidinedione derivative and its use as antidiabetic
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
WO2003050116A1 (fr) Sel d'acide 10-camphorsulphonique de 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione et son utilisation contre le diabete sucre
WO2003050112A1 (fr) Hydrates de toluenesulfonate d'un derive de thiazolidinedione
WO2003050111A1 (fr) Sels de type toluenesulfonate issus d'un derive de la thiazolidinedione
WO2003053963A1 (fr) Nouveau produit pharmaceutique
JP2005513038A (ja) ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンベンゼンスルホン酸塩；その製造方法；多形体ｉ、ｉｉおよびｉｉｉ；および医薬上活性な成分としてのその使用
WO2003050114A1 (fr) Sel de sulfate d'un derive de thiazolidinedione

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure